Literature DB >> 23955004

Immunity, inflammation, and bipolar disorder: diagnostic and therapeutic implications.

Nora Hamdani1, Raphael Doukhan, Ozlem Kurtlucan, Ryad Tamouza, Marion Leboyer.   

Abstract

Bipolar disorder is now known to be associated not only with highly prevalent co-occurring psychiatric and substance use disorders but also with medical comorbidities, such as cardiovascular diseases, diabetes mellitus, obesity and thyroid dysfunction. Inflammatory disturbances repeatedly observed in bipolar disorder, can explain some of the comorbidity between bipolar disorder and medical disorder. This revised perspective of bipolar disorders should promote the development of therapeutic tools. Immuno-inflammatory dysfunction may well represent a significant component of the underlying pathophysiology of the disorder. We therefore propose to review the immuno-inflammatory hypothesis in bipolar disorder considering the co-occurence with autoimmune diseases, immunological and inflammatory markers, as well as immuno-genetic markers which could lead to personalized treatments.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23955004     DOI: 10.1007/s11920-013-0387-y

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  87 in total

1.  The increasing medical burden in bipolar disorder.

Authors:  David J Kupfer
Journal:  JAMA       Date:  2005-05-25       Impact factor: 56.272

2.  High-sensitivity C-reactive protein levels in patients with major depressive disorder and bipolar mania.

Authors:  Tiao-Lai Huang; Fu-Chen Lin
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2006-10-24       Impact factor: 5.067

3.  Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder.

Authors:  Yong-Ku Kim; Hyun-Gang Jung; Aye-Mu Myint; Hyun Kim; Sun-Hwa Park
Journal:  J Affect Disord       Date:  2007-04-16       Impact factor: 4.839

4.  Relationship between Toxoplasma gondii infection and bipolar disorder in a French sample.

Authors:  Nora Hamdani; Claire Daban-Huard; Mohamed Lajnef; Jean-Romain Richard; Marine Delavest; Ophélia Godin; Emmanuel Le Guen; François-Eric Vederine; Jean-Pierre Lépine; Stéphane Jamain; Josselin Houenou; Philippe Le Corvoisier; Masayuki Aoki; Helene Moins-Teisserenc; Dominique Charron; Rajagopal Krishnamoorthy; Robert Yolken; Faith Dickerson; Ryad Tamouza; Marion Leboyer
Journal:  J Affect Disord       Date:  2012-12-27       Impact factor: 4.839

Review 5.  What does minor elevation of C-reactive protein signify?

Authors:  Irving Kushner; Debra Rzewnicki; David Samols
Journal:  Am J Med       Date:  2006-02       Impact factor: 4.965

Review 6.  Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors.

Authors:  Vincenzo Mollace; Carolina Muscoli; Emanuela Masini; Salvatore Cuzzocrea; Daniela Salvemini
Journal:  Pharmacol Rev       Date:  2005-06       Impact factor: 25.468

7.  Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder.

Authors:  Angelo B Cunha; Ana C Andreazza; Fabiano A Gomes; Benicio N Frey; Leonardo E da Silveira; Carlos A Gonçalves; Flávio Kapczinski
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-02-23       Impact factor: 5.270

8.  Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination.

Authors:  Joseph M Antony; Guido van Marle; Wycliffe Opii; D Allan Butterfield; François Mallet; Voon Wee Yong; John L Wallace; Robert M Deacon; Kenneth Warren; Christopher Power
Journal:  Nat Neurosci       Date:  2004-09-26       Impact factor: 24.884

9.  Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study.

Authors:  David E Laaksonen; Hanna-Maaria Lakka; Leo K Niskanen; George A Kaplan; Jukka T Salonen; Timo A Lakka
Journal:  Am J Epidemiol       Date:  2002-12-01       Impact factor: 4.897

10.  The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine.

Authors:  N Müller; M J Schwarz; S Dehning; A Douhe; A Cerovecki; B Goldstein-Müller; I Spellmann; G Hetzel; K Maino; N Kleindienst; H-J Möller; V Arolt; M Riedel
Journal:  Mol Psychiatry       Date:  2006-02-21       Impact factor: 15.992

View more
  27 in total

Review 1.  Obsessive-Compulsive Disorder: Autoimmunity and Neuroinflammation.

Authors:  Mona Gerentes; Antoine Pelissolo; Krishnamoorthy Rajagopal; Ryad Tamouza; Nora Hamdani
Journal:  Curr Psychiatry Rep       Date:  2019-08-01       Impact factor: 5.285

Review 2.  Gut microbiota and bipolar disorder: a review of mechanisms and potential targets for adjunctive therapy.

Authors:  Shakuntla Gondalia; Lisa Parkinson; Con Stough; Andrew Scholey
Journal:  Psychopharmacology (Berl)       Date:  2019-04-30       Impact factor: 4.530

Review 3.  Is it time for immunopsychiatry in psychotic disorders?

Authors:  Marion Leboyer; José Oliveira; Ryad Tamouza; Laurent Groc
Journal:  Psychopharmacology (Berl)       Date:  2016-03-18       Impact factor: 4.530

Review 4.  Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics.

Authors:  Robin Ortiz; Henning Ulrich; Carlos A Zarate; Rodrigo Machado-Vieira
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-11-07       Impact factor: 5.067

5.  Future Directions for Understanding Adolescent Bipolar Spectrum Disorders: A Reward Hypersensitivity Perspective.

Authors:  Lauren B Alloy; Robin Nusslock
Journal:  J Clin Child Adolesc Psychol       Date:  2019-03-25

6.  Antibody profiling of bipolar disorder using Escherichia coli proteome microarrays.

Authors:  Po-Chung Chen; Guan-Da Syu; Kuo-Hsuan Chung; Yu-Hsuan Ho; Feng-Hsiang Chung; Pao-Huan Chen; Jyun-Mu Lin; Yi-Wen Chen; Shang-Ying Tsai; Chien-Sheng Chen
Journal:  Mol Cell Proteomics       Date:  2014-12-24       Impact factor: 5.911

7.  Abnormal gene expression of proinflammatory cytokines and their receptors in the lymphocytes of patients with bipolar disorder.

Authors:  Ghanshyam N Pandey; Xinguo Ren; Hooriyah S Rizavi; Hui Zhang
Journal:  Bipolar Disord       Date:  2015-08-08       Impact factor: 6.744

Review 8.  Bipolar Disorder: Role of Inflammation and the Development of Disease Biomarkers.

Authors:  Ather Muneer
Journal:  Psychiatry Investig       Date:  2015-11-20       Impact factor: 2.505

Review 9.  Inflammatory biomarker profiles of mental disorders and their relation to clinical, social and lifestyle factors.

Authors:  David Baumeister; Alice Russell; Carmine M Pariante; Valeria Mondelli
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-05-01       Impact factor: 4.328

Review 10.  Secondary Mania induced by TNF-α inhibitors: A systematic review.

Authors:  Alessandro Miola; Veronica Dal Porto; Nicola Meda; Giulia Perini; Marco Solmi; Fabio Sambataro
Journal:  Psychiatry Clin Neurosci       Date:  2021-11-02       Impact factor: 12.145

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.